Senior Computational Biologist - Translational and Clinical Biomarkers
Recursion
Location
Salt Lake City, UT or New York City, NY (hybrid, 50% in-office)
Type
Full-time
Posted
Dec 15, 2025
Compensation
USD 151800 – 151800
Mission
What you will drive
- Evaluate molecular evidence for predictive and PD biomarker hypotheses in translational models and clinical samples
- Pilot novel methods for patient stratification and indication selection or expansion
- Deliver biological insights on therapeutic candidates and disease biology from analysis of high dimensional datasets
- Present data analysis to decision makers and stakeholders to drive toward getting medicines to patients
- Industrialize analysis approaches to accelerate future projects and scale impact
- Collaborate cross-functionally with data science, platform, ML and clinical teams to advance clinical data utilization
Impact
The difference you'll make
This role advances promising therapeutic candidates through clinical trials to develop life-changing medicines, working at the forefront of reimagining drug discovery to radically improve lives.
Profile
What makes you a great fit
- PhD in relevant field with 3+ years biotech/pharma experience OR MS with 5+ years experience in oncology/drug discovery
- Experience with high dimensional patient biomarker data from clinical trials in oncology
- Strong understanding of patient genetics and druggability of disease relevant pathways
- Experience applying computational methods (probabilistic, statistical, machine learning) to analyze complex biological/clinical data in Python or R
- Deep expertise in analysis and data integration of two or more 'omics data modalities
- Exceptional data visualization skills
- Excellent cross-functional communication skills
Benefits
What's in it for you
Estimated annual base range: $151,800 to $216,300 (USD). Eligible for annual bonus and equity compensation, plus comprehensive benefits package. Office-based hybrid role with at least 50% in-office work.
About
Inside Recursion
Recursion is a clinical stage TechBio company that decodes biology to radically improve lives through its Recursion OS platform, which generates one of the world's largest proprietary biological and chemical datasets using machine learning and massive computational scale.